Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.

Solomon SR, St Martin A, Shah NN, Fatobene G, Al Malki MM, Ballen KK, Bashey A, Bejanyan N, Bolaños Meade J, Brunstein CG, DeFilipp Z, Champlin RE, Fuchs EJ, Hamadani M, Hematti P, Kanakry CG, McGuirk JP, McNiece IK, Ciurea SO, Pasquini MC, Rocha V, Romee R, Patel SS, Vasu S, Waller EK, Wingard JR, Zhang MJ, Eapen M

Open source

DOI: 10.1182/bloodadvances.2019000627
Published: 2019 Oct 8
Container: Blood advances
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1182/bloodadvances.2019000627,
  title = {Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.},
  author = {Solomon SR and St Martin A and Shah NN and Fatobene G and Al Malki MM and Ballen KK and Bashey A and Bejanyan N and Bolaños Meade J and Brunstein CG and DeFilipp Z and Champlin RE and Fuchs EJ and Hamadani M and Hematti P and Kanakry CG and McGuirk JP and McNiece IK and Ciurea SO and Pasquini MC and Rocha V and Romee R and Patel SS and Vasu S and Waller EK and Wingard JR and Zhang MJ and Eapen M},
  year = {2019},
  journal = {Blood advances},
  doi = {10.1182/bloodadvances.2019000627},
  url = {https://doi.org/10.1182/bloodadvances.2019000627}
}

RIS

TY  - JOUR
TI  - Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.
AU  - Solomon SR
AU  - St Martin A
AU  - Shah NN
AU  - Fatobene G
AU  - Al Malki MM
AU  - Ballen KK
AU  - Bashey A
AU  - Bejanyan N
AU  - Bolaños Meade J
AU  - Brunstein CG
AU  - DeFilipp Z
AU  - Champlin RE
AU  - Fuchs EJ
AU  - Hamadani M
AU  - Hematti P
AU  - Kanakry CG
AU  - McGuirk JP
AU  - McNiece IK
AU  - Ciurea SO
AU  - Pasquini MC
AU  - Rocha V
AU  - Romee R
AU  - Patel SS
AU  - Vasu S
AU  - Waller EK
AU  - Wingard JR
AU  - Zhang MJ
AU  - Eapen M
PY  - 2019
JO  - Blood advances
DO  - 10.1182/bloodadvances.2019000627
UR  - https://doi.org/10.1182/bloodadvances.2019000627
ER  -

APA

SR, S., A, S. M., NN, S., G, F., MM, A. M., KK, B., A, B., N, B., J, B. M., CG, B., Z, D., RE, C., EJ, F., M, H., P, H., CG, K., JP, M., IK, M., SO, C., MC, P., V, R., R, R., SS, P., S, V., EK, W., JR, W., MJ, Z., & M, E. (2019). Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy.. Blood advances. https://doi.org/10.1182/bloodadvances.2019000627

Source records

pubmed · retrieved 2026-09-26T10:13:08.677Z